Clinical Focus
Business Focus
Spotlight
Subscribe
CE/CME
- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Screening
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
10 New Drugs for Primary Care: Q3 2019
The third quarter saw several novel drugs win FDA-approval for a variety of conditions often seen in primary care.
Another quarter has ended, which means Patient Care® Online has compiled another list of new FDA-approved drugs for primary care and they surely did not disappoint. Numerous "firsts" were approved for various conditions ranging from asthma to type 2 diabetes to pneumonia.
Click through the slideshow below to get details on the first and only glucagon-like peptide-1 analog in pill form; the first ready-to-use injection for hypoglycemia; the first digital inhaler for asthma that connects to a mobile app; and more.
Recent Videos
Related Content
